Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients-Reference-Cited by-同舟云学术

Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients

Published:2021-10-01 Issue:1 Volume:269 Page:452-459
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Río Jordi^ORCID,Rovira Àlex,Gasperini Claudio,Tintoré Mar,Prosperini Luca,Otero-Romero Susana,Comabella Manuel,Vidal-Jordana Ángela,Galán Ingrid,Midaglia Luciana,Rodriguez-Acevedo Breogán,Zabalza Ana,Castilló Joaquim,Arrambide Georgina,Nos Carlos,Cobo Álvaro,Tur Carmen,Auger Cristina,Sastre-Garriga Jaume,Montalban Xavier

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s00415-021-10823-z.pdf

Reference33 articles.

1. Rotstein D, Montalban X (2019) Reaching an evidence-based prognosis for personalized treatment of multiple sclerosis. Nat Rev Neurol 15(5):287–300

2. Gasperini C, Prosperini L, Tintoré M et al (2019) Unraveling treatment response in multiple sclerosis: a clinical and MRI challenge. Neurology 92:180–192

3. Sormani MP, De Stefano N (2013) Defining and scoring response to IFN-β in multiple sclerosis. Nat Rev Neurol 9:504–512

4. Río J, Castilló J, Rovira A et al (2009) Measures in the first year of therapy predict the response to interferon beta in MS. Mult Scler 15(7):848–853

5. Sormani M, Signori A, Stromillo M, De Stefano N (2013) Refining response to treatment as defined by the Modified Rio Score. Mult Scler 19(9):1246–1247

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurologic outcomes in people with multiple sclerosis treated with immune checkpoint inhibitors for oncologic indications;2024-06-13

2. Prognostic factors for disease activity in newly diagnosed teriflunomide-treated patients with multiple sclerosis: a nationwide Danish study;Journal of Neurology, Neurosurgery & Psychiatry;2024-04-03

3. Prediction of disease activity and treatment failure in relapsing–remitting MS patients initiating daily oral DMTs;Multiple Sclerosis Journal;2024-03-29

4. Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France;Neurology and Therapy;2024-03-15

5. Predictive value of individual serum neurofilament light chain levels in short-term disease activity in relapsing multiple sclerosis;Frontiers in Neurology;2024-02-14